Shares of Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT) rose sharply in pre-market trading after the FDA approved company’s ZORYVE topical foam, 0.3% for the treatment of seborrheic dermatitis in individuals aged 9 years and older.
Shares of Lantheus Holdings, Inc. (NASDAQ: LNTH) fell sharply during Monday’s session after the company and POINT Biopharma announced topline results from the pivotal phase 3 SPLASH study in metastatic castration-resistant prostate cancer.
Shares of Quanex Building Products Corporation (NYSE: NX) moved lower during Friday’s session after the company reported fourth-quarter financial results. Quanex Building Products shares fell 10.7% to $30.95 on Friday.
Northann’s (NYSE:NCL – Get Free Report) quiet period is set to end on Tuesday, November 28th. Northann had issued 1,200,000 shares in its initial public offering on October 19th. The total size of the offering was $6,000,000 based on an initial share price of $5.00. During Northann’s quiet period, insiders and any underwriters involved in […]